Chuang TD, Pearce WJ, Khorram O. miR-29c induction contributes to downregulation of vascular extracellular matrix proteins by glucocorticoids. Am J Physiol Cell Physiol 309: C117-C125, 2015. First published May 27, 2015 doi:10.1152/ajpcell.00254.2014.-Maternal undernutrition increases maternal glucocorticoids (GCs) and alters microRNA expression in offspring. Given that the mechanisms of GC action on vascular development are not clear, this study examined the influence of GCs on microRNA 29c (miR-29c) and its predicted targets in primary rat aorta smooth muscle cells (RAOSMCs). Dexamethasone (Dex) and corticosterone (Cor) time-dependently increased miR-29c expression and reduced collagen type III (Col3A1), collagen type IV (Col4A5), elastin (ELN), and matrix metalloproteinase-2 (MMP2) protein in RAOSMCs. These effects were blocked by mifepristone. These genes were also targeted by miR-29c, as confirmed by a significant decrease in luciferase reporter activity of Col3A1 (34%), Col4A5 (45%), ELN (17%), and MMP2 (28%). In cells transfected with reporter plasmids, including the 3=-untranslated region of genes targeted by miR-29c, treatment with Dex or Cor also resulted in decreases in luciferase activity. Gain or loss of function of miR-29c significantly altered mRNA expression of Col3A1 (26% and 26%, respectively), Col4A5 (28% and 32%, respectively), and MMP2 (24% and 14%, respectively) but did not affect ELN. Gain or loss of function of miR-29c also significantly altered protein levels of Col3A1 (51% and 16%, respectively), Col4A5 (56% and 22%, respectively), ELN (53% and 71%, respectively), and MMP2 (28% and 53%, respectively). Coincubation of anti-miR-29c with Dex or Cor partially attenuated the effects of these steroids on protein expression of Col3A1 (25% and 24%, respectively), Col4A5 (26% and 44%, respectively), ELN (31% and 55%, respectively), and MMP2 (46% and 26%, respectively) in RAOSMCs compared with anti-miR negative controls. Our results demonstrate that GCs regulate the expression of Col3A1, Col4A5, ELN, and MMP2, at least in part, through induction of miR-29c.
The chronic effects of GCs include restriction of fetal and placental growth, as indicated by decreased immunoreactivity for proliferating cell nuclear antigen and Ki-67, and induction of the cell cycle inhibitor proteins p27 and p57 (2, 12, 14) . GCs can also depress matrix metalloproteinase-9 (MMP9) expression (8) , downregulate ␤-integrin (10) and tenascin-C (30) , and differentially influence expression of fibronectin (11) and collagen type IV (37) in a variety of cell types. Together, these effects demonstrate the ability of GCs to potently modulate vascular structure and function. Consistent with this perspective, elevation of GCs by maternal food restriction induces increased stiffness and depressed contractile function in cerebral arteries from adult offspring (7) . The exact mechanisms mediating these vascular effects of GCs, however, remain uncertain.
In a previous study, elevated maternal GCs induced by undernutrition were correlated with elevated vascular levels of microRNA 29c (miR-29c) (13) . As for all microRNAs (miRNAs), miR-29c consists of a short nucleotide sequence with the potential to regulate the translation of certain genes (3) through base-pairing with the 3=-untranslated region (UTR) of target mRNAs, resulting in posttranslational repression (6) . For the miR-29 family (miR-29a, -29b, and -29c), target mRNAs code for proteins involved in cell differentiation, proliferation, and apoptosis (16, 19, 26, 27, 33) . Most importantly, these targets include collagens, ␤-integrin, and elastin (20, 22, 23, 34) , all of which are components of the vascular extracellular matrix (ECM). The overlap in effects of miR-29c and GCs on ECM proteins suggests that miR-29c may be involved in the effects of GCs on vascular stiffness and compliance. The present study was designed to test this hypothesis.
MATERIALS AND METHODS
Cell culture. Rat aortic smooth muscle cells (RAOSMCs) were purchased from Cell Applications (San Diego, CA) and cultured in the medium recommended by the supplier. Cells were cultured and used up to passage 4. Cells used for measurements were cultured for as long as 96 h, with and without treatments, before harvest. Dexamethasone (Dex), corticosterone (Cor), and mifepristone were purchased from Sigma-Aldrich (St. Louis, MO), dissolved in DMSO (0.2% final concentration), and then added to the cells. For control cells treated with DMSO, the duration of treatment was the same as for cells treated with Dex or Cor. At 0.2%, DMSO alone had no effects on expression of ECM mRNA or proteins in RAOSMCs at any measured time point (data not shown).
Gain-or loss-of-function studies with miR-29c. RAOSMCs were seeded at a density of 6 ϫ 10 4 /well in six-well plates and, at subconfluence, were transfected with 50 nM pre-miR-29c, anti-miR29c, pre-miR negative control (NC), or anti-miR NC (aNC) or Cy3-labeled NC oligonucleotides using PureFection transfection reagent (System Biosciences, Mountain View, CA). All oligonucleo-tides were obtained from Applied Biosystems (Grand Island, NY). Transfected cultures were maintained for 72-96 h before harvest.
RNA isolation and quantitative PCR analysis. Total RNA was extracted from cultured cells using TRIzol (Invitrogen, Grand Island, NY). The quantity and quality of the isolated RNA were determined spectrophotometrically (model ND-1000, NanoDrop Technologies, Wilmington, DE). RNA samples (10 ng) were reverse-transcribed using a specific stem-loop primer for miR-29c supplied by Applied Biosystems and determined by TaqMan miRNA expression assays (Applied Biosystems). For gene expression detection, 2-g RNA samples were reverse-transcribed using random primers; then quantitative RT-PCR was carried out using SYBR Green gene expression master mix (Applied Biosystems). Established primer sequences were used in the SYBR system for amplification of collagen type III [Col3A1; 5=-TTGGGATGCAACTACCTTGGT-3= (sense) and 5=-CCCGAGTCGCAGACACATATT-3= (antisense)], collagen type IV [Col4A5; 5=-ATTACTATGCCAATTCTTACAGCTTTTG-3= (sense) and 5=-TGTCCTCAAGTCGCCTGCTT-3= (antisense)], MMP-2 [5=-GCACCGTCGCCCATCA-3= (sense) and 5=-GCACTGCCAACTCTTT-GTCTGTT-3= (antisense)], elastin [ELN; 5=-AAAACCCCCGAAGC-CCTATG-3= (sense) and 5=-TCACTTTCTCTTCCGGCCAC-3= (antisense)], and 18S [5=-GACGGACCAGAGCGAAAGC-3= (sense) and 5=-CCTCCGACTTTCGTTCTTGATT-3= (antisense)]. Reactions were incubated for 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. Levels of mRNAs and miRNAs were quantified using the Invitrogen StepOne System and normalized to 18S and RNU6B, respectively. All reactions were run in triplicate, and relative expression was determined using the comparative cycle threshold (2 ⌬⌬CT ) method, as recommended by the supplier (Applied Biosystems). Abundance values are expressed as fold changes compared with the corresponding control group.
Immunoblotting. Total protein isolated from cells was subjected to immunoblotting as previously described (5) . The conditioned medium was collected and analyzed for ECM proteins secreted into the medium during culture. A Ponceau S-stained protein band on the nitrocellulose membrane was used as a loading control (not shown). Antibodies against MMP2 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), and antibodies against Col3A1, Col4A5, and ELN were obtained from Proteintech Group (Chicago, IL). After the initial quantitation of band densities for the main target proteins, the membranes were stripped and reprobed with an antibody against GAPDH (Proteintech Group), which served as a loading control. The proteins were analyzed on multiple different gels, each with its own GAPDH control. Band densities were quantified using ImageJ software (http://imagej.nih.gov/ij/).
Luciferase reporter assays. RAOSMCs were seeded in six-well plates and, upon reaching subconfluence, were transfected with 50 nM pre-miR-29c oligonucleotides or NC using the PureFection transfection reagent. At the same time, the cells were cotransfected with a luciferase reporter plasmid (1 g/well) containing a 3=-UTR sequence for one of the following genes: Col3A1, Col4A5, or MMP2 (GeneCopoeia, Rockville, MD) or ELN (Switchgear Genomics, Menlo Park, CA). Firefly and Renilla luciferase activities were measured after 48 h of transfection using the LucPair Duo-Luciferase assay kit (GeneCopoeia) and LightSwitch luciferase assay reagents (Switchgear Genomics). Firefly luciferase activity was normalized to Renilla luciferase activity, and the level of induction is reported as the mean Ϯ SE of three experiments performed in duplicate compared with that in cells transfected with the pre-miR NC.
Statistical analysis. All data sets were confirmed to be normally distributed and analyzed using two-way factorial univariate ANOVA for the effects of GC treatment and time or mifepristone on miR-29c expression (see Figs. 2 and 3 ). Two-sample unpaired t-tests were used to compare the effects of miR-29c with NC on relative luciferase activity from multiple reporter constructs (see Fig. 4 ). All statistical comparisons were made relative to values observed in DMSO-treated cells for exactly equivalent durations of culture. Two-way univariate ANOVAs were used to analyze the effects of miR-29c and anti-miR29c on mRNA and protein levels for multiple proteins (see Figs. 5 and 6) and the combined GC and anti-miR-29c treatments on protein levels for multiple target proteins (see Fig. 7 ). Variances were confirmed to be homogeneous within each ANOVA. Values are means Ϯ SE. Statistical significance implies P Ͻ 0.05, and for all nonsignificant comparisons, statistical power was Ն0.8.
RESULTS
GCs induce miR-29c and downregulate Col3A1, Col4A5, MMP2, and ELN. Transfection of RAOSMCs with Cy3-labeled NC oligonucleotides was highly efficient, as indicated in Fig. 1A . This result is consistent with the findings of Tang et al. (31) , who reported that oligonucleotide transfections were generally Ͼ90% efficient, whereas transfection efficiencies for whole plasmids were Ͻ25%. When RAOSMCs were transfected with a pre-miR sequence for miR-29c, the expression of miR-29c increased by 9,845 Ϯ 765 fold compared with cells transfected with NC (Fig. 1B) . Levels of miR-29c in cells transfected with anti-miR-29c were 0.53 Ϯ 0.11 fold of levels in cells transfected with aNC (Fig. 1C) .
Treatment with Dex and Cor decreased expression of four vascular proteins predicted as targets of miR-29c by TargetScan (www.targetscan.org): Col3A1, Col4A5, ELN, and MMP2. The effects of treatment with Dex and Cor were time-dependent (Fig. 2) (Fig. 2C) , while treatment with RU 26752, a mineralocorticoid receptor antagonist, did not block these effects (data not shown). In addition, treatment of RAOSMCs with 0.1 M Dex or 10 M Cor inhibited the secretion of Col3A1 and Col4A5 into the medium compared with treatment with DMSO alone (Fig.  2E) . Levels of ELN were not detectable in the conditioned medium at 24 or 48 h of culture. Treatment of RAOSMCs with Dex and Cor for only 12 h downregulated mRNA levels of Col3A1, Col4A5, ELN, and MMP2 (Fig. 2F) , indicating that GCs initially repressed expression of these genes through mRNA regulation.
Treatment with Dex and Cor also produced time-and concentration-dependent increases in miR-29c expression, as shown in Fig. 3 . The maximal effect for Dex was observed at 48 h and averaged 1.79 Ϯ 0.093 fold. The maximal effect for Cor was observed at 48 h and averaged 1.77 Ϯ 0.147 fold. The effects of both steroids on miR-29c were blocked at 36 h by treatment with mifepristone (Fig. 3C) .
miR-29c influences expression of Col3A1, Col4A5, MMP2, and ELN. In cultured RAOSMCs cotransfected for 48 h with luciferase reporter plasmids, including the 3=-UTR of genes targeted by miR-29c and either pre-miR-29c or a NC, expression of miR-29c depressed luciferase activity for Col3A1 (34%), Col4A5 (45%), ELN (17%), and MMP2 (28%) relative to the NC (Fig. 4B) . Treatment of cells transfected with reporter plasmids, including the 3=-UTR of genes targeted by miR-29c, also exhibited decreases in luciferase activity in response to treatment with Dex or Cor (Fig. 4C) . Transfection for 72 h with pre-miR-29c also decreased mRNA levels for Col3A1 (26%), Col4A5 (28%), and MMP2 (24%) relative to levels in the NC (Fig. 5) . Conversely, transfection with anti-miR-29c increased mRNA levels for Col3A1 (26%), Col4A5 (32%), and MMP2 (14%) relative to levels in the corresponding NC (Fig. 5) . Transfection with pre-miR-29c and anti-miR-29c had no effects on ELN mRNA in these experiments.
Effects miR-29c on protein expression of Col3A1, Col4A5, MMP2, and ELN. In cultured RAOSMCs, transfection for 96 h with pre-miR-29c depressed protein levels for Col3A1 (51%), Col4A5 (56%), ELN (53%), and MMP2 (28%) relative to transfection with the NC (Fig. 6, A and B) . Conversely, transfection with anti-miR-29c increased protein levels for Col3A1 (16%), Col4A5 (22%), ELN (71%), and MMP2 (53%) relative to levels in cells transfected with aNC (Fig. 6, C and D) .
In cells transfected with anti-miR-29c for 48 h, Dex was added and treatment continued for an additional 48 h (96 h total). Treatment with anti-miR-29c partially attenuated the inhibitory effects of Dex on levels of Col3A1 (25%), Col4A5 (26%), ELN (31%), and MMP2 (46%) relative to levels in cells transfected with aNC (Fig. 7C) . Similarly, anti-miR-29c transfection partially reversed the inhibitory effects of Cor on levels of Col3A1 (24%), Col4A5 (44%), ELN (55%), and MMP2 (26%) relative to levels in control-transfected cells (Fig. 7D) . For cyclooxygenase 2, a NC protein responsive to GC but not to miR-29c, expression was decreased to a similar extent in control and anti-miR-29c transfected cells for both Dex and Cor treatments.
DISCUSSION
This study offers six original findings in cultured RAOSMCs. 1) GCs decrease Col3A1, Col4A5, ELN, and MMP2 protein levels in a time-and GR-dependent manner. 2) GCs increase miR-29c in a time-and GR-dependent manner. 3) miR-29c regulates the 3=-UTR of Col3A1, Col4A5, ELN, and MMP2. 4) miR-29c and anti-miR-29c reciprocally decrease and increase mRNA levels, respectively, for Col3A1, Col4A5, and MMP2. 5) miR-29c and anti-miR-29c reciprocally decrease and increase protein levels, respectively, for Col3A1, Col4A5, ELN, and MMP2. 6) Enhanced anti-miR-29c expression can relieve GC inhibition of Col3A1, Col4A5, ELN, and MMP2 expres- sion. Together, these findings support the hypothesis that the antifibrotic effects of GCs on blood vessels are mediated, at least in part, through induction of miR-29c, which targets and downregulates multiple protein components of the ECM.
In light of suggestions that vascular responses to maternal undernutrition were mediated, at least in part, by GCs (17, 18) and that some effects of GCs involved miRNAs (28, 35) , we examined the effects of maternal undernutrition on miRNA expression in multiple tissues and observed major changes in miR-29c, a miRNA that targets multiple ECM proteins (13) . To study the possible involvement of miR-29c in GC action, we examined responses to Cor, an endogenous GC, and Dex, a long-acting fluorinated GC that induces its immediate biological effects through calcium signaling, a nongenomic mechanism, and produces its long-term effects through changes in gene expression via GRs (21) . To confirm involvement of miR-29c in response to endogenous and synthetic GCs, we used gain-of-function and knockdown transfections in RAOSMCs.
The present study employed cell culture to explore the involvement of miR-29c and GC signaling in RAOSMCs. Although this approach simplified transfections with miR-29c oligonucleotides, it also raises questions about the relevance of these results to the in vivo actions of GC in vascular smooth muscle. There are few studies on the in vivo effects of GC on matrix proteins and no studies addressing the role of miR-29c in vascular GC effects. In other cell types, GCs can depress MMP9 expression (8) , downregulate ␤-integrin (10) and tenascin-C (30), and differentially influence expression of fibronectin (11) . This pattern of protein targets, many of which are expressed by or associated with the vasculature, suggests that GC may modulate the composition and function of blood vessels. If so, then miR-29c may also contribute to the vascular effects of GC.
GCs have been reported to modulate the expression of many different miRNAs, including those that target genes involved in metabolism, differentiation, proliferation, and cell survival. One such miRNA, miR-27a, appears to mediate the effects of GCs on expression of the skeletal muscle anti-growth factor myostatin through a posttranscriptional mechanism (1). Expression of some intronic miRNAs, such as miR-223, miR-15b, and miR-16, has been correlated with expression of their host genes in cell lines and clinical samples of children with acute lymphoblastic leukemia undergoing systemic GC monotherapy (28) . In addition, GC can upregulate the miR-15b/16 cluster, which can arrest the cell cycle, in cell lines and acute lymphoblastic leukemia clinical samples, which helps explain the proapoptotic effect of GC in these tissues. Correspondingly, gain-of-function experiments with miR-15b/16 demonstrate enhanced proapoptotic effects of GC in leukemia cell lines, and, correspondingly, knockdown of miR-15b/16 attenuates sensitivity to GC (28) . In reciprocal fashion, expression of GR can be regulated by miR-18 and miR-124a in neuronal cells (32) , demonstrating that regulation of GRs and their downstream effects is closely integrated with the expression and function of miRNAs in multiple cell types.
The present study augments the list of miRNAs that interact with GCs and draws attention to the important effects of these molecules in the vasculature. Although the miR-29 family (miR-29a, -29b, and -29c) shares a common seed sequence predicted to target overlapping sets of genes, the individual members of this family exhibit differential regulation and subcellular distribution in different cell and tissue types, suggesting that their functional roles may be unique (15) . Expression of ELN has been reported to correlate inversely with miR-29b in vascular smooth muscle and aorta root aneurysms of Marfan syndrome (23, 24, 36) . miR-29b has also been shown to regulate the expression of Col3A1 and MMP2 through interaction with their 3=-UTR in HeLa cells (20) . Both miR-29b and miR-29c have been shown to target MMP2 in HEK293T (9), BeWo (19) , and 95D (34) cell types. For miR-29c, our luciferase reporter assays (Fig. 4) showed that Col3A1, Col4A5, ELN, and MMP2 are influenced by miR-29c in vascular smooth muscle cells (Fig. 4B) .
Interestingly, the effects of miR-29c on luciferase activity and mRNA abundance were not similarly coupled for all four proteins examined. Transfection with miR-29c decreased luciferase constructs with the 3=-UTR for Col3A1 and Col4A5 much more than for ELN or MMP2 (Fig. 4) . In contrast, miR-29c similarly depressed mRNA levels for Col3A1, Col4A5, and MMP2 without altering mRNA levels of ELN. At the protein level, miR-29c significantly depressed the abundances of all four proteins. Together, these results suggest that the relative effects of miR-29c on mRNA stabilization and translation are highly protein-specific: whereas miR-29c appears to influence mRNA stability and translation for Col3A1, Col4A5, and MMP2, its effects on ELN appear to be mediated primarily by inhibition of translation.
Overall, our results demonstrate that GCs, in a time-dependent manner, can downregulate expression of Col3A1, Col4A5, ELN, and MMP2 in cultured RAOSMCs (Fig. 2) through a GR-dependent mechanism (Fig. 2) . Given that GCs also in- creased expression of miR-29c in a time-dependent manner through a GR-dependent mechanism (Fig. 3) , our data suggest that GCs induce expression of miR-29c. Time-course studies suggest that the effects of GCs on ECM genes at least in vitro are not only mediated by miR-29c induction, because GCs inhibited the expression of the ECM genes at 12 h, whereas the induction of miR-29c by GCs occurred at 36 h, suggesting that miR-29c plays an accessory role in mediating the effects of GC. The initial effects of Cor and Dex on the mRNA levels for ECM genes (Fig. 2) suggest that GCs first regulate ECM genes through effects on mRNA transcription or turnover and then exert secondary effects through induction of miR-29c. Given that miR-29c can influence the 3=-UTR of multiple matrix proteins (Fig. 4) and can depress mRNA and protein for several of these proteins, we conclude that miR-29c mediates at least some of the later effects of GCs on ECM proteins in blood vessels. In support of this interpretation, transfection with anti-miR-29c enhanced mRNA and protein levels for multiple matrix proteins and relieved GC-mediated inhibition of expression of these proteins (Fig. 7) . Without doubt, our results do not suggest that miR-29c is the only miRNA involved in mediating the antifibrotic effects of GCs in blood vessels. They do, however, strongly justify the roles of other miRNAs in the vascular effects of GCs and, perhaps, other vasotrophic factors as well.
In summary, our data indicate that GCs in a concentrationand time-dependent manner inhibit the expression of key component proteins of the ECM, including Col3A1, Col4A5, ELN, and MMP2, in RAOSMCs in vitro and, at the same time, induce expression of miR-29c. Experiments with antagonist to miR-29c indicate that miR-29c, at least in part, mediates the inhibitory effect of GC on ECM gene expression. 6 . A: relative to effects of a control transfection (NC), a 96-h transfection of RAOSMCs with 50 nM pre-miR-29c (miR29c) significantly depressed protein levels for Col3A1, Col4A5, ELN, and MMP2. Immunoblots were prepared from 3 separate gels, and GAPDH was used as a loading control for each. B: when normalized relative to their corresponding GAPDH controls, all protein abundances were depressed significantly by transfection with pre-miR-29c. C: transfection with anti-miR-29c increased protein levels for Col3A1, Col4A5, ELN, and MMP2 relative to control (aNC). GAPDH was used as a loading control. D: when normalized relative to their corresponding GAPDH controls, all protein abundances were increased significantly by transfection with anti-miR-29c. Values are means Ϯ SE from 3 independent experiments. *P Ͻ 0.05 vs. control.
